We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
71 hedge funds and large institutions have $41.6M invested in Zevra Therapeutics in 2023 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
85% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 13
46% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 13
40% more call options, than puts
Call options by funds: $2.71M | Put options by funds: $1.93M
23% more capital invested
Capital invested by funds: $33.8M → $41.6M (+$7.75M)
18% more funds holding
Funds holding: 60 → 71 (+11)
6.32% more ownership
Funds ownership: 17.75% → 24.07% (+6.3%)
Holders
71
Holders Change
+11
Holders Change %
+18.33%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
19
Reduced
13
Closed
13
Calls
$2.71M
Puts
$1.93M
Net Calls
+$779K
Net Calls Change
+$967K
Top Buyers
| 1 |
BlackRock
New York
|
+$8.62M |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.61M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.9M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.17M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$736K |
Top Sellers
| 1 |
LCM
Laurion Capital Management
New York
|
-$3.14M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.91M |
| 3 |
Jane Street
New York
|
-$1.02M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$859K |
| 5 |
Millennium Management
New York
|
-$842K |
